RiverVest Venture Fund III, L.P. → OnKure Therapeutics, Inc. OKUR

Stake: 1.55% Shares: 196,198 CUSIP: 75974E103 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 1.00

163,904 shares short · +1958.6% vs prior

Post-Filing Returns · since 2025-01-16 on OKUR

+1 day

-3.7%

+5 days

-1.8%

+30 days

-5.3%

+60 days

-19.8%

+90 days

-51.2%

+180 days

-58.2%

Anchor price 6.01 on closest trading day on/after 2025-01-16. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on OnKure Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-04-07	SCHEDULE 13D	AI Biotechnology LLC	19.99%	9,091,532	view →

Other Filings by RiverVest Venture Fund III, L.P.

Filed	Form	Issuer	Stake	Shares
2025-01-10	SCHEDULE	SPRUCE BIOSCIENCES, INC. SPRB	4.20%	1,759,521	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →